BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24209907)

  • 1. Quality improvement guidelines for vascular access and closure device use.
    Sheth RA; Walker TG; Saad WE; Dariushnia SR; Ganguli S; Hogan MJ; Hohenwalter EJ; Kalva SP; Rajan DK; Stokes LS; Zuckerman DA; Nikolic B;
    J Vasc Interv Radiol; 2014 Jan; 25(1):73-84. PubMed ID: 24209907
    [No Abstract]   [Full Text] [Related]  

  • 2. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions.
    Patel IJ; Davidson JC; Nikolic B; Salazar GM; Schwartzberg MS; Walker TG; Saad WA;
    J Vasc Interv Radiol; 2012 Jun; 23(6):727-36. PubMed ID: 22513394
    [No Abstract]   [Full Text] [Related]  

  • 3. Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trial.
    Xhepa E; Byrne RA; Schulz S; Helde S; Gewalt S; Cassese S; Linhardt M; Ibrahim T; Mehilli J; Hoppe K; Grupp K; Kufner S; Böttiger C; Hoppmann P; Burgdorf C; Fusaro M; Ott I; Schneider S; Hengstenberg C; Schunkert H; Laugwitz KL; Kastrati A;
    EuroIntervention; 2014 Jun; 10(2):198-203. PubMed ID: 24952057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Society of Interventional Radiology Quality Improvement Standards for Percutaneous Transcatheter Embolization.
    Dariushnia SR; Redstone EA; Heran MKS; Cramer HR; Ganguli S; Gomes AS; Hogan MJ; Himes EA; Patel S; Schiro BJ; Lewis CA
    J Vasc Interv Radiol; 2021 Mar; 32(3):476.e1-476.e33. PubMed ID: 33640083
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure's Vascular Closure Device Speeds Hemostasis Trial).
    Wong SC; Bachinsky W; Cambier P; Stoler R; Aji J; Rogers JH; Hermiller J; Nair R; Hutman H; Wang H;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):785-93. PubMed ID: 19695549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of vascular closure devices outside the catheterization laboratory after neurointerventional procedures is safe and effective: evidence from a retrospective study.
    Khatri R; Rostambeigi N; Hassan AE; Carlson B; Rodriguez GJ; Qureshi AI
    J Endovasc Ther; 2012 Apr; 19(2):239-45. PubMed ID: 22545890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiva Catalyst II vascular access management device in percutaneous diagnostic and interventional procedures with same-day discharge (Catalyst II trial).
    Kiesz RS; Wiernek BK; Wiernek SL; Merritt C; Ybarra T; Iwanski A; Buszman PP; Szymanski R; Martin JL; Buszman PE
    J Endovasc Ther; 2011 Feb; 18(1):46-53. PubMed ID: 21314348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective evaluation of safety and effectiveness of the EXOSEAL vascular closure device for single vascular closure and closure after repeat puncture in diagnostic and interventional radiology: single-center experience.
    Boschewitz JM; Andersson M; Naehle CP; Schild HH; Wilhelm K; Meyer C
    J Vasc Interv Radiol; 2013 May; 24(5):698-702. PubMed ID: 23622041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comments regarding 'Influence of use of a vascular closure device on incidence and surgical management of access sites. Complications after percutaneous interventions'.
    Dosluoglu HH
    Eur J Vasc Endovasc Surg; 2011 Aug; 42(2):236-7. PubMed ID: 21592825
    [No Abstract]   [Full Text] [Related]  

  • 10. Re-access complication with a Starclose device.
    Varghese R; Chess D; Lasorda D
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):899-901. PubMed ID: 19455658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised comparison of manual compression and FemoSeal™ vascular closure device for closure after femoral artery access coronary angiography: the CLOSure dEvices Used in everyday Practice (CLOSE-UP) study.
    Holm NR; Sindberg B; Schou M; Maeng M; Kaltoft A; Bøttcher M; Krusell LR; Hjort J; Thuesen L; Terkelsen CJ; Christiansen EH; Bøtker HE; Kristensen SD; Lassen JF;
    EuroIntervention; 2014 Jun; 10(2):183-90. PubMed ID: 24603054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and treatment of local stenosis or occlusion at the vascular access site leading to limb ischemia and new-onset intermittent claudication after percutaneous interventions: implications of vascular closure devices.
    Klocker J; Gratl A; Chemelli A; Moes N; Goebel G; Pachinger O; Jaschke W; Fraedrich G
    Catheter Cardiovasc Interv; 2012 May; 79(6):938-43. PubMed ID: 21542117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the 6-F ExoSeal vascular closure device in antegrade femoral artery punctures.
    Maxien D; Behrends B; Eberhardt KM; Saam T; Thieme SF; Reiser MF; Treitl M
    J Endovasc Ther; 2012 Dec; 19(6):836-43. PubMed ID: 23210885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of contemporary vascular closure devices for the prevention of vascular complications after percutaneous coronary interventions in an all-comers PCI population.
    Kerré S; Kustermans L; Vandendriessche T; Bosmans J; Haine SE; Miljoen H; Vrints CJ; Beutels P; Wouters K; Claeys MJ
    EuroIntervention; 2014 Jun; 10(2):191-7. PubMed ID: 24952056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality improvement guidelines for percutaneous vertebroplasty.
    Baerlocher MO; Saad WE; Dariushnia S; Barr JD; McGraw JK; Nikolic B;
    J Vasc Interv Radiol; 2014 Feb; 25(2):165-70. PubMed ID: 24238815
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary: The Cardiva Catalyst II device: a catalyzer of patient safety or a boomerang for the endovascular specialist?
    Rezq A; Biondi-Zoccai G; Sangiorgi G
    J Endovasc Ther; 2011 Feb; 18(1):54-6. PubMed ID: 21314349
    [No Abstract]   [Full Text] [Related]  

  • 17. Early ambulation after percutaneous femoral access with use of closure devices and hemostatic agents.
    Engelbert TL; Scholten A; Thompson K; Spivack A; Kansal N
    Ann Vasc Surg; 2010 May; 24(4):518-23. PubMed ID: 20451795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of vascular closure devices after transbrachial artery access.
    Mirza AK; Steerman SN; Ahanchi SS; Higgins JA; Mushti S; Panneton JM
    Vasc Endovascular Surg; 2014; 48(7-8):466-9. PubMed ID: 25267690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of use of a vascular closure device on incidence and surgical management of access site complications after percutaneous interventions.
    Klocker J; Gratl A; Chemelli A; Moes N; Goebel G; Fraedrich G
    Eur J Vasc Endovasc Surg; 2011 Aug; 42(2):230-5. PubMed ID: 21498092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The StarClose vascular closure device in antegrade and retrograde punctures: a single-center experience.
    Chiu AH; Coles SR; Tibballs J; Nadkarni S
    J Endovasc Ther; 2010 Feb; 17(1):46-50. PubMed ID: 20199266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.